Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging.

Houston P, Goodman J, Lewis A, Campbell CJ, Braddock M.

FEBS Lett. 2001 Mar 9;492(1-2):73-7.

PMID:
11248240
[PubMed - indexed for MEDLINE]
Free Article
2.

Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.

Thapa N, Hong HY, Sangeetha P, Kim IS, Yoo J, Rhee K, Oh GT, Kwon IC, Lee BH.

J Control Release. 2008 Oct 6;131(1):27-33. doi: 10.1016/j.jconrel.2008.07.013. Epub 2008 Jul 16.

PMID:
18680772
[PubMed - indexed for MEDLINE]
3.

Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.

Hong HY, Lee HY, Kwak W, Yoo J, Na MH, So IS, Kwon TH, Park HS, Huh S, Oh GT, Kwon IC, Kim IS, Lee BH.

J Cell Mol Med. 2008 Oct;12(5B):2003-14. doi: 10.1111/j.1582-4934.2008.00189.x.

PMID:
19012727
[PubMed - indexed for MEDLINE]
4.

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.

Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.

Cardiovasc Res. 2009 May 1;82(2):371-81. doi: 10.1093/cvr/cvp036. Epub 2009 Jan 28.

PMID:
19176597
[PubMed - indexed for MEDLINE]
Free Article
5.

Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.

Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.

Life Sci. 2008 Mar 26;82(13-14):708-17. doi: 10.1016/j.lfs.2008.01.006. Epub 2008 Jan 26.

PMID:
18289605
[PubMed - indexed for MEDLINE]
6.

A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.

Park K, Hong HY, Moon HJ, Lee BH, Kim IS, Kwon IC, Rhee K.

J Control Release. 2008 Jun 24;128(3):217-23. doi: 10.1016/j.jconrel.2008.03.019. Epub 2008 Mar 28.

PMID:
18457896
[PubMed - indexed for MEDLINE]
7.

Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.

Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L.

Circulation. 2003 Jun 3;107(21):2726-32. Epub 2003 May 12.

PMID:
12742997
[PubMed - indexed for MEDLINE]
Free Article
8.

Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.

Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu H, Zhang Y, Satoskar AR, David JR, Metz CN, Bucala R, Fang K, Simon DI, Chapman HA, Libby P, Shi GP.

Circulation. 2004 Jun 29;109(25):3149-53. Epub 2004 Jun 14.

PMID:
15197138
[PubMed - indexed for MEDLINE]
Free Article
9.

Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice.

Hockings PD, Roberts T, Galloway GJ, Reid DG, Harris DA, Vidgeon-Hart M, Groot PH, Suckling KE, Benson GM.

Circulation. 2002 Sep 24;106(13):1716-21.

PMID:
12270868
[PubMed - indexed for MEDLINE]
Free Article
10.

Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.

Parks BW, Lusis AJ, Kabarowski JH.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2703-9. Epub 2006 Sep 21.

PMID:
16990555
[PubMed - indexed for MEDLINE]
Free Article
11.

Organ targeting in vivo using phage display peptide libraries.

Pasqualini R, Ruoslahti E.

Nature. 1996 Mar 28;380(6572):364-6.

PMID:
8598934
[PubMed - indexed for MEDLINE]
12.

Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.

Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.

Circulation. 2003 Apr 1;107(12):1640-6. Epub 2003 Mar 24.

PMID:
12668499
[PubMed - indexed for MEDLINE]
Free Article
13.

Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.

Gordts PL, Reekmans S, Lauwers A, Van Dongen A, Verbeek L, Roebroek AJ.

Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1258-64. doi: 10.1161/ATVBAHA.109.192211. Epub 2009 Aug 10.

PMID:
19667105
[PubMed - indexed for MEDLINE]
Free Article
14.

No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.

Torzewski M, Reifenberg K, Cheng F, Wiese E, K├╝pper I, Crain J, Lackner KJ, Bhakdi S.

Thromb Haemost. 2008 Jan;99(1):196-201. doi: 10.1160/TH07-10-0595.

PMID:
18217154
[PubMed - indexed for MEDLINE]
15.

Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.

Lee GY, Kim JH, Oh GT, Lee BH, Kwon IC, Kim IS.

J Control Release. 2011 Oct 30;155(2):211-7. doi: 10.1016/j.jconrel.2011.07.010. Epub 2011 Jul 14.

PMID:
21781994
[PubMed - indexed for MEDLINE]
16.

The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice.

Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L.

Atherosclerosis. 2005 Jul;181(1):29-37. Erratum in: Atherosclerosis. 2005 Oct;182(2):381.

PMID:
15939051
[PubMed - indexed for MEDLINE]
17.

ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.

Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD, Knapper CL, Syed J, Wu J, Vaisman BL, Fruchart-Najib J, Billings EM, Paigen B, Remaley AT, Santamarina-Fojo S, Brewer HB Jr.

J Biol Chem. 2006 Nov 3;281(44):33053-65. Epub 2006 Aug 23.

PMID:
16928680
[PubMed - indexed for MEDLINE]
Free Article
18.

The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.

Cilingiroglu M, Ozer K.

Curr Atheroscler Rep. 2005 Mar;7(2):103-7.

PMID:
15727724
[PubMed - indexed for MEDLINE]
19.

LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.

Chen M, Masaki T, Sawamura T.

Pharmacol Ther. 2002 Jul;95(1):89-100. Review.

PMID:
12163130
[PubMed - indexed for MEDLINE]
20.

Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype.

Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP.

Blood. 2004 Feb 1;103(3):934-40. Epub 2003 Sep 25.

PMID:
14512319
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk